PAG
HZNP

Private Advisor Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Private Advisor Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-600
Closed -$4K – 2003
2020
Q4 		$4K Buy
+600
New +$44.6K ﹤0.01% 1768

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Private Advisor Group's HZNP Position: Q4 2023 in Review

Private Advisor Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 6,368 shares — an estimated $737K sold.

Private Advisor Group first reported a position in HZNP in Q4 2019 and held it in 15 quarters. The position peaked at $12.5M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Private Advisor Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Private Advisor Group sold 6,368 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $737K.
  • Private Advisor Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2019 and held it in 15 quarters.
  • Private Advisor Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $12.5M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Private Advisor Group's 13F filing for Q4 2023, filed 6 Feb 2024.